Breast cancer in adolescents and young adults

RH Johnson, CK Anders, JK Litton… - Pediatric blood & …, 2018 - Wiley Online Library
Breast cancer is the most common cancer of adolescents and young adult (AYA) women
aged 15 to 39 years, accounting for 5.6% of all invasive breast cancer in women. In …

Breast cancer in the 21st century: from early detection to new therapies

JAM Bonilla, MT Tabanera, LHR Mendoza - Radiología (English Edition), 2017 - Elsevier
The analysis of the causes that have given rise to a change in tendency in the incidence and
mortality rates of breast cancer in the last few decades generates important revelations …

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

S Yadav, NJ Boddicker, J Na, EC Polley… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To estimate the risk of contralateral breast cancer (CBC) among women with
germline pathogenic variants (PVs) in ATM, BRCA1, BRCA2, CHEK2, and PALB2 …

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

K Kerlikowske, AM Molinaro… - Journal of the …, 2010 - academic.oup.com
Background Studies have failed to identify characteristics of women who have been
diagnosed with ductal carcinoma in situ (DCIS) and have a high or low risk of subsequent …

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study

M Stovall, SA Smith, BM Langholz, JD Boice Jr… - International Journal of …, 2008 - Elsevier
PURPOSE: To quantify the risk of second primary breast cancer in the contralateral breast
(CB) after radiotherapy (RT) for first breast cancer. METHODS AND MATERIALS: The study …

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

SA Narod, JS Brunet, P Ghadirian, M Robson… - The Lancet, 2000 - thelancet.com
Background Women with a mutation in BRCA1 or BRCA2 have a high risk of developing
breast cancer and of contralateral cancer after the initial diagnosis of breast cancer …

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

KA Phillips, RL Milne, MA Rookus, MB Daly… - Journal of clinical …, 2013 - ascopubs.org
Purpose To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is
associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and/or BRCA2 …

[图书][B] The vulnerable empowered woman: Feminism, postfeminism, and women's health

TN Dubriwny - 2012 - books.google.com
The feminist women's health movement of the 1960s and 1970s is credited with creating
significant changes in the healthcare industry and bringing women's health issues to public …

Second primary cancer risk-the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study

A Coyte, DS Morrison, P McLoone - BMC cancer, 2014 - Springer
Background There is evidence that cancer survivors are at increased risk of second primary
cancers. Changes in the prevalence of risk factors and diagnostic techniques may have …

Incidence and prognosis of synchronous and metachronous bilateral breast cancer

M Hartman, K Czene, M Reilly, J Adolfsson… - Journal of Clinical …, 2007 - ascopubs.org
Purpose Because the incidence of breast cancer is increasing and prognosis is improving, a
growing number of women are at risk of developing bilateral disease. Little is known …